Kaskela Law LLC is investigating Tyra Biosciences, Inc. (NASDAQ: TYRA) (“Tyra”) on behalf of the company’s shareholders.
Since March 2024, shares of Tyra’s common stock have declined over 15% in value, from a trading value of approximately $20.00 per share to a current trading price of less than $17.00 per share.
The investigation seeks to determine whether Tyra and/or the company’s representatives violated the securities laws by issuing false and/or misleading statements, or by failing to disclose material information to investors, thereby causing investor losses.
Tyra shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (888) 715 – 1740 or 484-229-0750, or by completing the form on this page, for additional information about this investigation and their legal rights and options.